255 related articles for article (PubMed ID: 32860009)
1. Current evidence on screening for renal cancer.
Usher-Smith J; Simmons RK; Rossi SH; Stewart GD
Nat Rev Urol; 2020 Nov; 17(11):637-642. PubMed ID: 32860009
[TBL] [Abstract][Full Text] [Related]
2. Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
Diana P; Klatte T; Amparore D; Bertolo R; Carbonara U; Erdem S; Ingels A; Kara O; Marandino L; Marchioni M; Muselaers S; Pavan N; Pecoraro A; Pecoraro A; Roussel E; Campi R;
World J Urol; 2023 Apr; 41(4):929-940. PubMed ID: 35362747
[TBL] [Abstract][Full Text] [Related]
3. The haphazard approach to the early detection of asymptomatic renal cancer: results from a contemporary executive health programme.
Feldstein MS; Rhodes DJ; Parker AS; Orford RR; Castle EP
BJU Int; 2009 Jul; 104(1):53-6. PubMed ID: 19154476
[TBL] [Abstract][Full Text] [Related]
4. The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review.
Sohlberg EM; Metzner TJ; Leppert JT
Eur Urol Focus; 2019 Nov; 5(6):943-945. PubMed ID: 30905599
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and screening for renal cancer.
Rossi SH; Klatte T; Usher-Smith J; Stewart GD
World J Urol; 2018 Sep; 36(9):1341-1353. PubMed ID: 29610964
[TBL] [Abstract][Full Text] [Related]
6. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
8. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
9. Expert Elicitation to Inform a Cost-Effectiveness Analysis of Screening for Renal Cancer.
Rossi SH; Blick C; Nathan P; Nicol D; Stewart GD; Wilson ECF
Value Health; 2019 Sep; 22(9):981-987. PubMed ID: 31511187
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic and prognostic markers of renal cell carcinoma].
Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759
[TBL] [Abstract][Full Text] [Related]
11. A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound.
Rossi SH; Klatte T; Usher-Smith JA; Fife K; Welsh SJ; Dabestani S; Bex A; Nicol D; Nathan P; Stewart GD; Wilson ECF
Eur Urol Focus; 2021 Mar; 7(2):407-419. PubMed ID: 31530498
[TBL] [Abstract][Full Text] [Related]
12. The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer.
Usher-Smith JA; Godoy A; Burge SW; Burbidge S; Cartledge J; Crosbie PAJ; Eckert C; Farquhar F; Hammond D; Hancock N; Iball GR; Kimuli M; Masson G; Neal RD; Rogerson S; Rossi SH; Sala E; Smith A; Sharp SJ; Simmonds I; Wallace T; Ward M; Callister MEJ; Stewart GD
BMJ Open; 2022 Sep; 12(9):e063018. PubMed ID: 36127097
[TBL] [Abstract][Full Text] [Related]
13. Screening computed tomography: will it result in overdiagnosis of renal carcinoma?
Fenton JJ; Weiss NS
Cancer; 2004 Mar; 100(5):986-90. PubMed ID: 14983494
[TBL] [Abstract][Full Text] [Related]
14. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
15. Genetic kidney cancer syndromes.
Ho TH; Jonasch E
J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
[TBL] [Abstract][Full Text] [Related]
16. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer.
Vasudev NS; Wilson M; Stewart GD; Adeyoju A; Cartledge J; Kimuli M; Datta S; Hanbury D; Hrouda D; Oades G; Patel P; Soomro N; Sullivan M; Webster J; Selby PJ; Banks RE
BMJ Open; 2020 May; 10(5):e035938. PubMed ID: 32398335
[TBL] [Abstract][Full Text] [Related]
17. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
